Osivax Company

Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.

Founded Date: 2017-01-01
Funding Status: Early Stage Venture
Total Funding: 46143932
Employee Number: 11-50
Headquarters: Lyon, Rhone-Alpes, France
Last Funding Date: 2020-07-08
Investors Number: 5
Last Funding Type: Grant
Estimated Revenue: $1M to $10M
Industry: Atrificial Vectors and Immune Cells